These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

750 related items for PubMed ID: 29864964

  • 1. Drug targets exploited in Mycobacterium tuberculosis: Pitfalls and promises on the horizon.
    Bhat ZS, Rather MA, Maqbool M, Ahmad Z.
    Biomed Pharmacother; 2018 Jul; 103():1733-1747. PubMed ID: 29864964
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. New tuberculosis drugs on the horizon.
    Cole ST, Riccardi G.
    Curr Opin Microbiol; 2011 Oct; 14(5):570-6. PubMed ID: 21821466
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Perspective: Challenges and opportunities in TB drug discovery from phenotypic screening.
    Manjunatha UH, Smith PW.
    Bioorg Med Chem; 2015 Aug 15; 23(16):5087-97. PubMed ID: 25577708
    [Abstract] [Full Text] [Related]

  • 7. Recent advances in the research of heterocyclic compounds as antitubercular agents.
    Yan M, Ma S.
    ChemMedChem; 2012 Dec 15; 7(12):2063-75. PubMed ID: 23042656
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Current Advances in Antitubercular Drug Discovery: Potent Prototypes and New Targets.
    Dos Santos Fernandes GF, Jornada DH, de Souza PC, Chin CM, Pavan FR, Dos Santos JL.
    Curr Med Chem; 2015 Dec 15; 22(27):3133-61. PubMed ID: 26282941
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cell wall: A versatile fountain of drug targets in Mycobacterium tuberculosis.
    Bhat ZS, Rather MA, Maqbool M, Lah HU, Yousuf SK, Ahmad Z.
    Biomed Pharmacother; 2017 Nov 15; 95():1520-1534. PubMed ID: 28946393
    [Abstract] [Full Text] [Related]

  • 12. Discovery of antitubercular 2,4-diphenyl-1H-imidazoles from chemical library repositioning and rational design.
    Pieroni M, Wan B, Zuliani V, Franzblau SG, Costantino G, Rivara M.
    Eur J Med Chem; 2015 Jul 15; 100():44-9. PubMed ID: 26071857
    [Abstract] [Full Text] [Related]

  • 13. In silico analyses for the discovery of tuberculosis drug targets.
    Chung BK, Dick T, Lee DY.
    J Antimicrob Chemother; 2013 Dec 15; 68(12):2701-9. PubMed ID: 23838951
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Harnessing Biological Insight to Accelerate Tuberculosis Drug Discovery.
    de Wet TJ, Warner DF, Mizrahi V.
    Acc Chem Res; 2019 Aug 20; 52(8):2340-2348. PubMed ID: 31361123
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.